- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07571668
Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral Palsy
Effects of Robotic Hand Therapy in Comparison to Conventional Therapy on Hand Function and Dexterity in Children With Hemiplegic Cerebral Palsy; a Randomized Controlled Trial
This randomized controlled trial aims to evaluate the effects of robotic hand therapy using the Syrebo E12 soft-robotic glove compared with conventional physiotherapy on hand function and manual dexterity in children with hemiplegic cerebral palsy. Children aged 7-15 years, classified as GMFCS I-III and MACS I-III, will be recruited from multiple rehabilitation centers in Pakistan. Participants will be randomly allocated (1:1) to either robotic therapy or standard physiotherapy, receiving 45-minute sessions, three times per week for 8 weeks.
The primary outcome is functional hand performance measured by the Jebsen-Taylor Hand Function Test (JTHFT). Secondary outcomes include ABILHAND-Kids, Box and Block Test, Nine-Hole Peg Test, grip strength, and qualitative feedback. Assessments will occur at baseline, week 4, week 8, and at a 6-month follow-up. A mixed-effects repeated-measures ANCOVA will be used for analysis following the intention-to-treat principle.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Qamar Mehmood, Ph.D.
- Número de teléfono: +923335151063
- Correo electrónico: qamar.mehmood@riphah.edu.pk
Ubicaciones de estudio
-
-
-
Islamabad, Pakistán
- Riphah International University
-
Contacto:
- Mudassar Ali, Ph.D*
- Número de teléfono: +923015255090
- Correo electrónico: mudassarpt@gmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Patients diagnosed with Hemiplegic type of Cerebral palsy
- Age 7 to 15 years
- Ability to understand and follow simple instructions
- Gross Motor Function Classification System (GMFCS) levels I-III (ambulatory)
- Manual Ability Classification system (MACS) I to III
- Stable medical condition (no major changes in medication or therapy in the past 3 months).
Exclusion Criteria:
- Patients with severe cognitive dysfunction.
- Fixed contractures or deformities of the upper limb that would prevent safe use of the robotic device.
- Recent upper limb surgery, botulinum toxin injection, or casting within the past 6 months.
- Uncontrolled epilepsy or other unstable medical conditions.
- Visual or auditory impairments that would interfere with assessment or therapy.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Fisioterapia Convencional
|
Participants in this group will receive conventional physical therapy based on neurodevelopmental and task-oriented principles, including stretching, strengthening, sensory re-education, and functional hand-use training.
Sessions will last 45 minutes, three times per week for six weeks, delivered by a licensed physical therapist following a standardized treatment checklist.
The program targets improvements in hand strength, dexterity, range of motion, and fine motor skills, with safety and treatment fidelity monitored throughout.
|
|
Experimental: Robotic Hand Therapy
|
Participants in this group will receive robotic hand therapy using a glove-based robotic rehabilitation device that provides passive, active-assisted, and resistive training to facilitate repetitive, task-specific hand movements.
Each 45-minute session will be delivered three times per week for six weeks under therapist supervision, focusing on improving grasp-release patterns, finger mobility, and functional hand use.
Therapy intensity will be progressively adjusted based on performance and tolerance, and all sessions will be monitored for safety and adverse events.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Jebsen-Taylor Hand Function Test
Periodo de tiempo: 8 Weeks
|
Jebsen-Taylor Hand Function Test (JTHFT) will objectively quantify functional capacity of hand.
|
8 Weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
ABILHAND-Kids
Periodo de tiempo: 8 Weeks
|
ABILHAND-Kids for perceived manual ability in daily activities (Subjective assessment).
|
8 Weeks
|
|
Box and Block Test
Periodo de tiempo: 8 Weeks
|
Box and Block Test [BBT] for unilateral gross manual dexterity
|
8 Weeks
|
|
Nine-Hole Peg Test (NHPT)
Periodo de tiempo: 8 weeks
|
Nine-Hole Peg Test (NHPT) fine finger dexterity (time to place and remove pegs)
|
8 weeks
|
|
o'connor test
Periodo de tiempo: 8 Weeks
|
The O'Connor Finger Dexterity Test is a, standardized, timed, aptitude assessment designed to measure fine motor skills and rapid, precise manipulation of small objects.
It is widely used in vocational testing, industrial hiring (assembly line work), and clinical rehab to evaluate finger dexterity by placing three pins into 100 holes.
|
8 Weeks
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Qamar Mehmood, Ph.D., Riphah International University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- RCRAHS-ISB/REC/PhD/011110
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .